BURIONI ROBERTO has a total of 13 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SHANGHAI PHARMAEXPLORER CO LTD, I MAB and DIMITROV DIMITER S.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 1 | |
#4 | EAPO (Eurasian Patent Organization) | 1 | |
#5 | Italy | 1 | |
#6 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Combinatorial chemistry | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Burioni Roberto | 13 |
#2 | Clementi Massimo | 7 |
#3 | Maisano Federico | 1 |
#4 | Canducci Filippo | 1 |
Publication | Filing date | Title |
---|---|---|
US2012165211A1 | Human Antibodies Cross-Reacting With A Bacterial And A Self Antigen From Atherosclerotic Plaques | |
US2011256140A1 | Anti-HCV monoclonal antibody as a medicament for the therapeutic treatment and prevention of HCV infections | |
WO2010035292A1 | The use of a human monoclonal anti-hcv antibody as a medicament for the therapeutic treatment and prevention of hcv infections | |
US2009203548A1 | Complex able to detect an analyte, method for its preparation and uses thereof |